BMY Aug 2025 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:37AM EDT. Market open.
Loading interactive chart...
- Zacks
Walmart Earnings & the State of the Consumer
We discuss what Walmart's blockbuster results tell us about the health of the consumer economy.
- Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
- Business Wire
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
PRINCETON, N.J., May 16, 2024--New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
© 2024 Yahoo. All rights reserved.